C&EN3 个月
Farnesyl Transferase Inhibitors as a Novel Strategy for Targeting KRAS-Dependent Cancers
Although early FTIs faced challenges related to alternative geranylgeranylation, newer-generation FTIs, including tipifarnib or Compound (1), effectively block KRAS farnesylation, curtailing oncogenic ...